Literature DB >> 3242835

Quantification of arrhythmias using scoring systems: an examination of seven scores in an in vivo model of regional myocardial ischaemia.

M J Curtis1, M J Walker.   

Abstract

Arrhythmia scores have been used in recent years to facilitate the analysis of arrhythmias, particularly in relation to regional myocardial ischaemia. The recent Lambeth Conventions recommended caution in the use of arrhythmia scores since their use may be misleading. In the present study seven scoring systems were examined in an attempt to validate the use of arrhythmia scores. A strong positive correlation was present between all seven scores. Furthermore, the scores all correlated with the incidences of ventricular fibrillation, ventricular tachycardia, and ventricular premature beats in early myocardial ischaemia. All seven scores successfully detected statistically significant reductions in the incidence of ventricular fibrillation resulting from the administration of two drugs. Some of the scores occasionally showed statistically significant reductions when effects on the raw arrhythmia data were not statistically significant. In this respect, parametric statistical analysis of arrhythmia scores may be a more sensitive method of quantifying arrhythmias than non-parametric analysis of binomially distributed raw data such as the incidence of ventricular fibrillation (in accordance with the power of such tests) indicating that the scores have precision. However, none of the scores incorrectly showed a statistically significant reduction when the raw data expressed a statistically significant or non-significant increase, indicating that the scores have accuracy. In conclusion, it is possible to design many arrhythmia scores that show changes in arrhythmia severity when more conventional analyses show only non-statistically significant trends. When used in conjunction with raw arrhythmia data, comprehensive drug dose ranges, and appropriate parametric statistical tests, arrhythmia scores facilitate the quantification of arrhythmias. It is recommended that arrhythmia scores should be used only for quantifying group data and model building and not for prognostic purposes in individuals.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3242835     DOI: 10.1093/cvr/22.9.656

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  87 in total

1.  A rabbit Langendorff heart proarrhythmia model: predictive value for clinical identification of Torsades de Pointes.

Authors:  C L Lawrence; M H Bridgland-Taylor; C E Pollard; T G Hammond; J-P Valentin
Journal:  Br J Pharmacol       Date:  2006-10-09       Impact factor: 8.739

2.  Upregulation of SERCA2a following short-term ACE inhibition (by enalaprilat) alters contractile performance and arrhythmogenicity of healthy myocardium in rat.

Authors:  Marek Matus; Dana Kucerova; Peter Kruzliak; Adriana Adameova; Gabriel Doka; Katarina Turcekova; Jana Kmecova; Jan Kyselovic; Peter Krenek; Uwe Kirchhefer; Frank U Mueller; Peter Boknik; Jan Klimas
Journal:  Mol Cell Biochem       Date:  2015-02-08       Impact factor: 3.396

3.  Ultrafine Particulate Matter Increases Cardiac Ischemia/Reperfusion Injury via Mitochondrial Permeability Transition Pore.

Authors:  Nathan A Holland; Chad R Fraiser; Ruben C Sloan; Robert B Devlin; David A Brown; Christopher J Wingard
Journal:  Cardiovasc Toxicol       Date:  2017-10       Impact factor: 3.231

4.  Preconditioning with PEP-1-SOD1 fusion protein attenuates ischemia/reperfusion-induced ventricular arrhythmia in isolated rat hearts.

Authors:  Zunping Ke; Aimei Gao; Peng Xu; Jianing Wang; Lijuan Ji; Jianye Yang
Journal:  Exp Ther Med       Date:  2015-04-22       Impact factor: 2.447

5.  Cardioprotective and antiarrhythmic effect of U50,488H in ischemia/reperfusion rat heart.

Authors:  Liang Cheng; Sai Ma; Long-Xiao Wei; Hai-Tao Guo; Lu-Yu Huang; Hui Bi; Rong Fan; Juan Li; Ya-Li Liu; Yue-Min Wang; Xin Sun; Quan-Yu Zhang; Shi-Qiang Yu; Ding-Hua Yi; Xin-Liang Ma; Jian-Ming Pei
Journal:  Heart Vessels       Date:  2007-09-20       Impact factor: 2.037

6.  Overexpression of adenylyl cyclase type 5 (AC5) confers a proarrhythmic substrate to the heart.

Authors:  Zhenghang Zhao; Gopal J Babu; Hairuo Wen; Nadezhda Fefelova; Richard Gordan; Xiangzhen Sui; Lin Yan; Dorothy E Vatner; Stephen F Vatner; Lai-Hua Xie
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-12-05       Impact factor: 4.733

7.  Tanshinone IIA protects against sudden cardiac death induced by lethal arrhythmias via repression of microRNA-1.

Authors:  Hongli Shan; Xuelian Li; Zhenwei Pan; Li Zhang; Benzhi Cai; Yong Zhang; Chaoqian Xu; Wenfeng Chu; Guofen Qiao; Baoxin Li; Yanjie Lu; Baofeng Yang
Journal:  Br J Pharmacol       Date:  2009-09-23       Impact factor: 8.739

8.  Cardiac arrhythmias induced by glutathione oxidation can be inhibited by preventing mitochondrial depolarization.

Authors:  David A Brown; Miguel A Aon; Chad R Frasier; Ruben C Sloan; Andrew H Maloney; Ethan J Anderson; Brian O'Rourke
Journal:  J Mol Cell Cardiol       Date:  2009-12-03       Impact factor: 5.000

9.  Electrophysiological and antiarrhythmic actions of the kappa agonist PD 129290, and its R,R (+)-enantiomer, PD 129289.

Authors:  M K Pugsley; D A Saint; M P Penz; M J Walker
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

10.  Cardiac sodium/calcium exchanger preconditioning promotes anti-arrhythmic and cardioprotective effects through mitochondrial calcium-activated potassium channel.

Authors:  Jian-Ying Zhang; Kang Cheng; Dong Lai; Ling-Heng Kong; Min Shen; Fu Yi; Bing Liu; Feng Wu; Jing-Jun Zhou
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.